Founder Bill Wells To Retire
May 24 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS EXECUTIVE CHAIRMAN AND CO-FOUNDER BILL
WELLS TO
RETIRE
* HLS THERAPEUTICS INC - GREG GUBITZ HAS BEEN APPOINTED
CHAIR OF
BOARD EFFECTIVE IMMEDIATELY
* HLS THERAPEUTICS INC - WELLS INTENDS TO FOCUS ON OTHER
BUSINESS
INTERESTS AND HAS AGREED TO WORK WITH CO TO FACILITATE AN
ORDERLY TRANSITION
Source text for Eikon: ID:nCNWW90QWa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group